FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

Celldex Therapeutics, Inc.: capex

One fact, its scope and the complete path back to the official record.

Period: 2024-01-01 – 2024-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/6e97e7f1-6a49-47b9-a080-babdf3e2df5d

Reported value

$1.919M{"amount": 1919000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Entity
Celldex Therapeutics, Inc.
Metric
capex
Period
2024-01-01 – 2024-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001410578-25-000216 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T07:49:49.488008+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0000744218/capex/2024-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.